Description

Viatris’ $150 Million Headwind — Can Growth And Pipeline Momentum Offset Nashik?

Viatris reported second-quarter 2026 financial results reflecting continued operational revenue growth, strong profitability, and progress across its global product portfolio and pipeline. Total revenues were $3.8 billion, representing a 3.5% operational increase year-over-year, driven primarily by growth in Greater China and solid performance in complex generics and branded products in North America. Adjusted EBITDA was $1.2 billion, and adjusted EPS reached $0.69, both exceeding company expectations. Adjusted gross margin improved to 57.5%, attributed to favorable product mix and strong regional performances. Operating expenses declined as a percentage of revenues due to ongoing strategic cost containment initiatives. Commercial execution remained a strength, with Greater China delivering 16% net sales growth, supported by investments in marketing and e-commerce platforms, which accounted for approximately 10–15% of the region’s business.